Stay updated on Pembrolizumab in Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Biliary Tract Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page shows a new revision label (v3.5.4) replacing the previous v3.5.3, indicating a deployed update to the site’s software. This update does not modify study details or data presented on the page.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a minor site/version maintenance update without changing the study details.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be an internal platform update with no visible changes to the study content.SummaryDifference0.1%

- Check66 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor site version update with no visible changes to the study page.SummaryDifference0.1%

- Check102 days agoChange DetectedRevision: v3.4.2 has been added; the page content and purpose remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.